We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current RZLT market cap is 131.16M. The company's latest EPS is USD -1.3069 and P/E is -2.56.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -14.39M | -17.14M | -14.24M | -15.91M | -15.19M |
| Net Income | -13.56M | -15.67M | -12.73M | -14.52M | -13.91M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -25.93M | -20.52M | -22.89M | -41.84M | -55.99M |
| Net Income | -30.45M | -20.33M | -20.9M | -41.06M | -51.79M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 150.21M | 134.21M | 123.72M | 113M | 102.15M |
| Total Liabilities | 8.94M | 6.89M | 7.55M | 9.44M | 10.42M |
| Total Equity | 141.27M | 127.32M | 116.17M | 103.56M | 91.73M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 12.25M | 10.97M | 42.61M | 152.42M | 123.72M |
| Total Liabilities | 10.5M | 3.6M | 16.51M | 2.95M | 7.55M |
| Total Equity | 1.75M | 7.37M | 26.1M | 149.47M | 116.17M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -15.08M | -33.13M | -44.48M | -10.59M | -23.61M |
| Investing | -153k | -95.11M | -101.46M | 2.61M | 20.37M |
| Financing | 11.57M | 11.57M | 11.57M | N/A | -293k |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -15.3M | -24.17M | -20.44M | -39.62M | -44.48M |
| Investing | 231k | N/A | N/A | N/A | -101.46M |
| Financing | 25M | 22.55M | 51.53M | 148.98M | 11.57M |
| Market Cap | 131.16M |
| Price to Earnings Ratio | -2.56 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 8.25 |
| Price to Book Ratio | 1.14 |
| Dividend Yield | - |
| Shares Outstanding | 39.63M |
| Average Volume (1 week) | 164.06k |
| Average Volume (1 Month) | 313.94k |
| 52 Week Change | 55.40% |
| 52 Week High | 3.69 |
| 52 Week Low | 0.72 |
| Spread (Intraday) | 0.22 (6.47%) |
| Company Name | Rezolute Inc |
| Address |
187 e warm springs road las vegas, nevada 89119 |
| Website | https://www.rezolutebio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
